Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (45)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by King, A.
Right arrow Articles by Phillips, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, A.
Right arrow Articles by Phillips, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 219-223
© 2001 The British Society for Antimicrobial Chemotherapy

The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates

Anna King*, and Ian Phillips

Department of Infection, KCL, St Thomas' Hospital Campus, London SE1 7EH, UK

The in vitro activity of daptomycin was assessed in comparison with that of vancomycin and penicillin against a wide range of Gram-positive aerobic clinical isolates. MICs were determined by an agar dilution method on Mueller–Hinton agar (NCCLS/EUCAST) and on Isotonic agar adjusted to contain 50 mg/L free calcium (BSAC). Both media were enriched with 5% horse blood for fastidious organisms. Daptomycin MICs for all 172 staphylococci, including methicillin-susceptible and methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus, were 0.03–0.5 mg/L. For 99 of the 100 enterococci (Enterococcus faecalis, n = 50; Enterococcus faecium, n = 50), including 37 vancomycin-resistant isolates, they were 0.25–2 mg/L. For all 108 ß-haemolytic streptococci, including Streptococcus pyogenes and Streptococcus agalactiae, daptomycin MICs were 0.016– 0.25 mg/L; for 101 {alpha}-haemolytic streptococci, including Streptococcus pneumoniae and ‘viridans’ streptococci, they were 0.016–2 mg/L. For miscellaneous vancomycin-resistant isolates including Lactobacillus spp., Lactococcus spp., Leuconostoc spp., Pediococcus spp. and isolates of Enterococcus casseliflavus and Enterococcus gallinarum, daptomycin MICs were 0.03–2 mg/L; MICs for the seven isolates of Listeria monocytogenes were 0.25–4 mg/L. There was little difference between the results on Mueller–Hinton agar and on supplemented Isotonic agar The discrepant results occasionally obtained tended to be one dilution higher on supplemented Isotonic agar. Daptomycin was active (MICs <= 2 mg/L) against all the isolates tested with the exception of one isolate each of E. faecium and L. monocytogenes (MICs = 4 mg/L). Our results indicate that daptomycin MICs are independent of methicillin and vancomycin MICs.

* Corresponding author. Tel: +44-20-7928-9292 ext. 2456; Fax: +44-20-7928-0730; E-mail: anna.king{at}kcl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
N. Cotroneo, R. Harris, N. Perlmutter, T. Beveridge, and J. A. Silverman
Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2223 - 2225.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Spanjaard and C. M. J. E. Vandenbroucke-Grauls
Activity of Daptomycin against Listeria monocytogenes Isolates from Cerebrospinal Fluid
Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1850 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
R. J. Attwood and K. L. LaPlante
Telavancin: A novel lipoglycopeptide antimicrobial agent
Am. J. Health Syst. Pharm., November 15, 2007; 64(22): 2335 - 2348.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
I. Klare, C. Konstabel, S. Muller-Bertling, R. Reissbrodt, G. Huys, M. Vancanneyt, J. Swings, H. Goossens, and W. Witte
Evaluation of New Broth Media for Microdilution Antibiotic Susceptibility Testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria
Appl. Envir. Microbiol., December 1, 2005; 71(12): 8982 - 8986.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
V. Miao, M.-F. Coeffet-LeGal, P. Brian, R. Brost, J. Penn, A. Whiting, S. Martin, R. Ford, I. Parr, M. Bouchard, et al.
Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry
Microbiology, May 1, 2005; 151(5): 1507 - 1523.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. M. Streit, J. N. Steenbergen, G. M. Thorne, J. Alder, and R. N. Jones
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis
J. Antimicrob. Chemother., April 1, 2005; 55(4): 574 - 578.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Cottagnoud, M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kuhn, H.-P. Muller, and A. Stucki
Daptomycin Is Highly Efficacious against Penicillin-Resistant and Penicillin- and Quinolone-Resistant Pneumococci in Experimental Meningitis
Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3928 - 3933.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J.-J. Lai and S. K Brodeur
Physical and Chemical Compatibility of Daptomycin with Nine Medications
Ann. Pharmacother., October 1, 2004; 38(10): 1612 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. P. Johnson, S. Mushtaq, M. Warner, and D. M. Livermore
Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar
J. Antimicrob. Chemother., May 1, 2004; 53(5): 860 - 862.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. C. Fluit, F.-J. Schmitz, J. Verhoef, and D. Milatovic
In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance Determinants
Antimicrob. Agents Chemother., March 1, 2004; 48(3): 1007 - 1011.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
I. Phillips, M. Casewell, T. Cox, B. De Groot, C. Friis, R. Jones, C. Nightingale, R. Preston, and J. Waddell
Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data
J. Antimicrob. Chemother., January 1, 2004; 53(1): 28 - 52.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Alder, T. Li, D. Yu, L. Morton, J. Silverman, X.-X. Zhang, I. Critchley, and G. Thorne
Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection
Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3561 - 3566.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. K. Dandekar, P. R. Tessier, P. Williams, C. H. Nightingale, and D. P. Nicolau
Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model
J. Antimicrob. Chemother., September 1, 2003; 52(3): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. A. Silverman, N. G. Perlmutter, and H. M. Shapiro
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2538 - 2544.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
V. Laganas, J. Alder, and J. A. Silverman
In Vitro Bactericidal Activities of Daptomycin against Staphylococcus aureus and Enterococcus faecalis Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2682 - 2684.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. Vaudaux, P. Francois, C. Bisognano, D. Li, D. P. Lew, and J. Schrenzel
Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus
J. Antimicrob. Chemother., July 1, 2003; 52(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. S. Richter, D. E. Kealey, C. T. Murray, K. P. Heilmann, S. L. Coffman, and G. V. Doern
The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species
J. Antimicrob. Chemother., July 1, 2003; 52(1): 123 - 127.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
I. A. Critchley, R. S. Blosser-Middleton, M. E. Jones, C. Thornsberry, D. F. Sahm, and J. A. Karlowsky
Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001
Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1689 - 1693.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
I. A. Critchley, D. C. Draghi, D. F. Sahm, C. Thornsberry, M. E. Jones, and J. A. Karlowsky
Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001
J. Antimicrob. Chemother., March 1, 2003; 51(3): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum
Bactericidal activity of daptomycin against Streptococcus pneumoniae compared with eight other antimicrobials
J. Antimicrob. Chemother., February 1, 2003; 51(2): 443 - 446.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.